NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
GREENAlendronic Acid
(Tablets) 		Endocrine system, Bisphosphonates, 06.06.02
GREENIbandronic Acid
(Tablets) 		Endocrine system, Bisphosphonates, 06.06.02
REDIbandronic Acid injection  Endocrine system, Bisphosphonates, 06.06.02
REDPamidronate Disodium Injection  Endocrine system, Bisphosphonates, 06.06.02
GREENRisedronate
(Tablets) 		Endocrine system, Bisphosphonates, 06.06.02
REDRomosozumab Evenity®
(105 mg solution for injection in pre-filled pen) 		Endocrine system, Bisphosphonates and other drugs affecting bone metabolism, 06.06.02
Amber SPASodium Clodronate
(Tablets) 		Endocrine system, Bisphosphonates, 06.06.02
REDZoledronic Acid 4mg
(Injection for infusion) 		Endocrine system, Bisphosphonates, 06.06.02
REDZoledronic Acid 5mg
(Intravenous infusion) 		Endocrine system, Bisphosphonates, 06.06.02
Non Formulary items found
Status Description Section
 Ibandronic Acid 50mg
(Tablets) 		Endocrine system, Bisphosphonates, 06.06.02
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Alendronic  Alendronic Acid Endocrine System, Bone Metabolism Disorders
Alendronic  Alendronic Acid With Colecalciferol Endocrine System, Bone Metabolism Disorders
Ibandronic  Ibandronic Acid Endocrine System, Bone Metabolism Disorders
Ibandronic  Ibandronic Acid Malignant Disease, Secondary Bone Metastases And Hypercalcaemia
Pamidronate  Pamidronate Disodium Endocrine System, Bone Metabolism Disorders
Pamidronate  Pamidronate Disodium Malignant Disease, Secondary Bone Metastases And Hypercalcaemia
Risedronate Risedronate Sodium Endocrine System, Bone Metabolism Disorders
Risedronate Risedronate With Calcium Carbonate And Colecalciferol Endocrine System, Bone Metabolism Disorders
SODIUM  Sodium Clodronate Endocrine System, Bone Metabolism Disorders
SODIUM  Sodium Clodronate Malignant Disease, Secondary Bone Metastases And Hypercalcaemia
Zoledronic  Zoledronic Acid Endocrine System, Bone Metabolism Disorders
Zoledronic  Zoledronic Acid Malignant Disease, Secondary Bone Metastases And Hypercalcaemia
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
Bisphosphonates: osteonecrosis of the jaw
MHRA Drug Safety Update (July 2015) - Denosumab (Xgeva▼, Prolia); intravenous bisphosphonates: osteonecrosis of the jaw—further measures to minimise risk
MHRA Drug Safety Update (July 2015) - Denosumab (Xgeva▼, Prolia); intravenous bisphosphonates: osteonecrosis of the jaw—further measures to minimise risk
NICE TA464: Bisphosphonates for treating osteoporosis